Hypoloside A



Compound IDCDAMM01518
Common nameHypoloside A
IUPAC name[4,5-dihydroxy-6-(hydroxymethyl)-2-(7-hydroxy-2,2,5,7-tetramethyl-1-oxospiro[3,7a-dihydroindene-6,1\'-cyclopropane]-3a-yl)oxyoxan-3-yl] acetate
Molecular formulaC23H34O9

Experimental data

Retention time4.47
Adduct[M+NH4]+
Actual mz472.25
Theoretical mz472.254
Error7.67
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.1634

Identifiers and class information

Inchi keyRYLFQOVBQSESBN-LHOHVAGVNA-N
SmilesO=C(OC1C(OC(CO)C(O)C1O)OC23C=C(C)C4(CC4)C(O)(C)C3C(=O)C(C)(C)C2)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)454.516
Computed dipole moment(dipole)4.835
Total solvent accessible surface area (SASA)680.988
Hydrophobic component of SASA (FOSA)501.724
Hydrophilic component of SASA (FISA)173.181
Pie component of the SASA (PISA)6.082
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1337.06
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)11.3
Free energy of solvation of dipole (dip^2/V)0.0174841
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0287409
Globularity descriptor (glob)0.861903
Predicted polarizability in cubic angstroms (QPpolrz)42.276
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.535
Predicted octanol/gas partition coefficient (QPlogPoct)24.597
Predicted water/gas partition coefficient (QPlogPw)16.337
Predicted octanol/water partition coefficient (QPlogPo/w)1.699
Predicted aqueous solubility (QPlogS)-3.571
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.919
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.796
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)225.746
Predicted brain/blood partition coefficient (QPlogBB)-1.473
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)99.013
Predicted skin permeability, log Kp (QPlogKp)-3.922
PM3 calculated ionization potential (IP(ev))9.805
PM3 calculated electron affinity (EA(eV))-0.568
Number of likely metabolic reactions (#metab)6
Prediction of binding to human serum albumin (QPlogKhsa)-0.171
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)79.017
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)148.17
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P17931LGALS3Galectin-3T72038SEA
Q07108CD69Early activation antigen CD69T48780SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3

Copyright © 2025